Clinical Trials Directory

Trials / Completed

CompletedNCT04676581

Risk Benefit Ratio of Hirudotherapy: Retrospective Single-center Study of 37 Cases Over a Period of 9 Years

Status
Completed
Phase
Study type
Observational
Enrollment
37 (actual)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
6 Years
Healthy volunteers
Not accepted

Summary

Venous congestion in transplanted or re-implanted tissues remains a common and chal-lenging complication in plastic and reconstructive surgery. Local application of medicinal leeches is effective to reduce postoperative venous congestion of the flap and to restore normal blood flow. However, leech therapy is associated with a number of risks, including infections. Indeed, leeches maintain a symbiotic relationship with Aeromonas species in order to digest blood in their gut. Aeromonas spp. infections can occur 1 to 30 days post-application of leeches and are associated with a dramatic decrease in flap salvage rates (88 to 30%). For these reasons, prophylactic antibiotics and, external decontamination are widely recommended throughout the course of leech therapy. The aim of this study is to investigate the prevalence of side effects (anemia and infection) from patients treated with leeches in French Hospital.

Conditions

Interventions

TypeNameDescription
OTHERLeech TherapyPatient who received leeches (for more than 2 days) at the Amiens University Hospital over a period of 9 years (2010-2018)

Timeline

Start date
2020-12-15
Primary completion
2020-12-15
Completion
2020-12-15
First posted
2020-12-21
Last updated
2020-12-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04676581. Inclusion in this directory is not an endorsement.

Risk Benefit Ratio of Hirudotherapy: Retrospective Single-center Study of 37 Cases Over a Period of 9 Years (NCT04676581) · Clinical Trials Directory